Sign in

CIK 0001651308 · Large accelerated filer

BeOne Medicines Ltd.

Sign in to watch
Ticker
BEIGF
Exchange
Nasdaq, OTC
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
operating
EIN
981209416
Phone
41-616851900
Business address
C/O BEONE MEDICINES I GMBH, AESCHENGRABEN 27, 21ST FLOOR, BASEL, Switzerland, 4051
Former names
BeiGene, Ltd.

Securities

  • ONC American Depositary Shares Nasdaq
  • BEIGF Common stock OTC
  1. 144 Insider Sale of Securities
  2. 144 Insider Sale of Securities
  3. 144 Insider Sale of Securities
  4. 8-K Event Executive or director change · Shareholder vote results
  5. 4 Open-market sale Principal Accounting Officer sold 136 shares at an average $271.33 ($36,901)
  6. 4 Open-market sale SVP, General Counsel sold 871 shares at an average $270.42 ($235,539)
  7. 4 Open-market sale President, Global Head of R&D sold 1,367 shares at an average $269.38 ($368,247)
  8. 4 Open-market sale President and COO sold 1,484 shares at an average $269.37 ($399,738)
  9. 4 Open-market sale Chief Executive Officer sold 4,940 shares at an average $270.56 ($1,336,548)
  10. 144 Insider Sale of Securities
  11. 144 Insider Sale of Securities
  12. 144 Insider Sale of Securities
  13. 144 Insider Sale of Securities
  14. 144 Insider Sale of Securities
  15. 4 Open-market sale Director sold 235 shares at $279.13 ($65,596)
  16. 144 Insider Sale of Securities
  17. 4 Open-market sale Director sold 212 shares at $309.51 ($65,617)
  18. 4 Open-market sale Director sold 212 shares at $309.60 ($65,636)
  19. 4 Open-market sale Director sold 212 shares at $309.59 ($65,633)
  20. 4 Open-market sale Director sold 10,998 shares at an average $23.82 ($261,981)

Page 5 of 64 · 1,277 filings